Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 97 (3), 383-388
- https://doi.org/10.1016/j.ijcard.2003.10.018
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophyJournal Of Hypertension, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Candesartan Cilexetil Improves Left Ventricular Function, Left Ventricular Hypertrophy, and Endothelial Function in Patients With Hypertensive Heart Disease.Circulation Journal, 2002
- Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor RamiprilCirculation, 2001
- Regression of Left Ventricular Hypertrophy and Improved PrognosisCirculation, 2001
- Regression of left ventricular hypertrophy in human hypertension with irbesartanJournal Of Hypertension, 2001
- Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertensionAmerican Journal of Hypertension, 2001
- Left ventricular hypertrophy and angiotensin II antagonists.American Journal of Hypertension, 2001
- Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential HypertensionCirculation, 1998
- Reversal of Left Ventricular Hypertrophy in Hypertensive PatientsAmerican Journal of Hypertension, 1992